Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Publisher Name :
Date: 01-Jul-2017
No. of pages: 78
Inquire Before Buying

Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Dengue Virus Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dengue Virus Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dengue Virus Diagnostic Tests under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Dengue Virus Diagnostic Tests and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Dengue Virus Diagnostic Tests under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

Dengue Virus Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Dengue Virus Diagnostic Tests Overview 6
3 Products under Development 7
3.1 Dengue Virus Diagnostic Tests - Pipeline Products by Stage of Development 7
3.2 Dengue Virus Diagnostic Tests - Pipeline Products by Territory 8
3.3 Dengue Virus Diagnostic Tests - Pipeline Products by Regulatory Path 9
3.4 Dengue Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date 10
4 Dengue Virus Diagnostic Tests - Pipeline Products under Development by Companies 11
4.1 Dengue Virus Diagnostic Tests Companies - Pipeline Products by Stage of Development 11
4.2 Dengue Virus Diagnostic Tests - Pipeline Products by Stage of Development 12
5 Dengue Virus Companies and Product Overview 13
5.1 Acobiom Company Overview 13
5.1.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Arkray Inc Company Overview 14
5.2.1 Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Ceres Nanosciences Inc Company Overview 15
5.3.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 15
5.4 Corgenix Medical Corp Company Overview 16
5.4.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 16
5.5 GeneFirst Ltd Company Overview 17
5.5.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
5.6 GlowDx Company Overview 18
5.6.1 GlowDx Pipeline Products & Ongoing Clinical Trials Overview 18
5.7 InBios International Inc Company Overview 19
5.7.1 InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.8 Innova Biotechnology Co Ltd Company Overview 20
5.8.1 Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
5.9 Institut Pasteur Company Overview 21
5.9.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 21
5.10 Malaysian Bio-Diagnostics Research Sdn Bhd Company Overview 22
5.10.1 Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview 22
5.11 McGill University Company Overview 23
5.11.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 23
5.12 Micronics Inc Company Overview 24
5.12.1 Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.13 Mologic Ltd Company Overview 25
5.13.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
5.14 Pictor Ltd Company Overview 26
5.14.1 Pictor Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.15 QuantuMDx Group Ltd Company Overview 27
5.15.1 QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
5.16 Quidel Corp Company Overview 28
5.16.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.17 Sansure Biotech Inc Company Overview 29
5.17.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.18 Universitas Padjadjaran Company Overview 30
5.18.1 Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview 30
5.19 University of Texas Medical Branch at Galveston Company Overview 31
5.19.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 31
5.20 Whidiag SAS Company Overview 32
5.20.1 Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 32
6 Dengue Virus Diagnostic Tests - Recent Developments 33
6.1 Jun 14, 2017: Alere Reports First Quarter 2017 Financial Results 33
6.2 Jun 05, 2017: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results 33
6.3 May 22, 2017: Alere Provides Preliminary Unaudited Financial Results 34
6.4 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results 35
6.5 Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 36
6.6 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 37
6.7 Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016 38
6.8 Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 39
6.9 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors 41
6.10 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day 42
6.11 Mar 09, 2017: Alere Provides Update on Arriva Medical 43
6.12 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 43
6.13 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results 45
6.14 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 48
6.15 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 49
6.16 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 50
6.17 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 50
6.18 Jan 04, 2017: Alere Provides Update on Arriva Medical 51
6.19 Dec 28, 2016: Alere Provides Update on Arriva Medical 51
6.20 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 52
6.21 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 52
6.22 Nov 29, 2016: genedrive: Update on CFO Appointment 53
6.23 Nov 10, 2016: Response Biomedical Announces Third Quarter 2016 Financial Results 53
6.24 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 54
6.25 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent 54
6.26 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 55
6.27 Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 57
6.28 Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016 59
6.29 Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer 65
6.30 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 66
6.31 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 66
6.32 Aug 12, 2016: Response Biomedical Announces Second Quarter 2016 Financial Results 67
6.33 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 67
6.34 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results 69
6.35 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results 70
6.36 Jul 25, 2016: Epistem Holdings Announces Re change of name, TIDM and website address 71
6.37 Jul 21, 2016: Trinity Biotech Announces Quarter 2 Financial Results 72
6.38 Jul 11, 2016: Epistem Holdings Announces Result of General Meeting and Change of Name 73
7 Appendix 75
7.1 Methodology 75
7.2 About GlobalData 78
7.3 Contact Us 78
7.4 Disclaimer 78

1.1 List of Tables
Table 1: Dengue Virus Diagnostic Tests - Pipeline Products by Stage of Development 7
Table 2: Dengue Virus Diagnostic Tests - Pipeline Products by Territory 8
Table 3: Dengue Virus Diagnostic Tests - Pipeline Products by Regulatory Path 9
Table 4: Dengue Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date 10
Table 5: Dengue Virus Diagnostic Tests Companies - Pipeline Products by Stage of Development 11
Table 6: Dengue Virus - Pipeline Products by Stage of Development 12
Table 7: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: Diagnostic Test - Dengue - Product Status 13
Table 9: Diagnostic Test - Dengue - Product Description 13
Table 10: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: Dengue Prognostic Test Kit - Product Status 14
Table 12: Dengue Prognostic Test Kit - Product Description 14
Table 13: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 15
Table 14: Dengue Virus Test - Product Status 15
Table 15: Dengue Virus Test - Product Description 15
Table 16: Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 16
Table 17: Dengue Virus Test Kit - Product Status 16
Table 18: Dengue Virus Test Kit - Product Description 16
Table 19: GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 17
Table 20: PCDR - Dengue Test - Product Status 17
Table 21: PCDR - Dengue Test - Product Description 17
Table 22: GlowDx Pipeline Products & Ongoing Clinical Trials Overview 18
Table 23: Diagnostic Test - Dengue Fever - Product Status 18
Table 24: Diagnostic Test - Dengue Fever - Product Description 18
Table 25: InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 26: DENV Detect IgA Capture ELISA - Product Status 19
Table 27: DENV Detect IgA Capture ELISA - Product Description 19
Table 28: Innova Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 29: Rapid Test - Dengue Fever - Product Status 20
Table 30: Rapid Test - Dengue Fever - Product Description 20
Table 31: Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 21
Table 32: Diagnostic Assay - Dengue - Product Status 21
Table 33: Diagnostic Assay - Dengue - Product Description 21
Table 34: Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview 22
Table 35: Diagnostic Test - Dengue Fever - Product Status 22
Table 36: Diagnostic Test - Dengue Fever - Product Description 22
Table 37: McGill University Pipeline Products & Ongoing Clinical Trials Overview 23
Table 38: Biomarker Assay - Dengue - Product Status 23
Table 39: Biomarker Assay - Dengue - Product Description 23
Table 40: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 41: Wallet Test - Dengue - Product Status 24
Table 42: Wallet Test - Dengue - Product Description 24
Table 43: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
Table 44: Dengue Fever Diagnostic Test - Professional Use - Product Status 25
Table 45: Dengue Fever Diagnostic Test - Professional Use - Product Description 25
Table 46: Pictor Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
Table 47: Diagnostic Test - Dengue Fever - Product Status 26
Table 48: Diagnostic Test - Dengue Fever - Product Description 26
Table 49: QuantuMDx Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 50: Q-POC - Dengue Fever Assay - Product Status 27
Table 51: Q-POC - Dengue Fever Assay - Product Description 27
Table 52: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 53: IsoAmp Assay - Dengue - Product Status 28
Table 54: IsoAmp Assay - Dengue - Product Description 28
Table 55: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 56: Dengue Fever Virus General-Type Diagnostic Kit - Product Status 29
Table 57: Dengue Fever Virus General-Type Diagnostic Kit - Product Description 29
Table 58: Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview 30
Table 59: Rapid Molecular Assay - Dengue - Product Status 30
Table 60: Rapid Molecular Assay - Dengue - Product Description 30
Table 61: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 31
Table 62: Biomarker Based Assay - Dengue Virus Infection - Product Status 31
Table 63: Biomarker Based Assay - Dengue Virus Infection - Product Description 31
Table 64: Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview 32
Table 65: Rapid Diagnostic Test - Dengue Virus - Product Status 32
Table 66: Rapid Diagnostic Test - Dengue Virus - Product Description 32
Table 67: Glossary 77

1.2 List of Figures
Figure 1: Dengue Virus Diagnostic Tests - Pipeline Products by Stage of Development 7
Figure 2: Dengue Virus Diagnostic Tests - Pipeline Products by Territory 8
Figure 3: Dengue Virus Diagnostic Tests - Pipeline Products by Regulatory Path 9
Figure 4: Dengue Virus Diagnostic Tests - Pipeline Products by Estimated Approval Date 10
  • Point-ofCare Diagnostics Market 2021: Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Test Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 12500 Onwards        Pages: 0
    This new 1,007-page report from VPGMarketResearch.com contains 180 tables, provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies.RationaleThe ......
  • Point-of-Care Infectious Disease Market 2021: Physician Offices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers--Supplier Shares, Test Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 5500 Onwards        Pages: 0
    This new 795-page report from VPGMarketResearch.com contains 61 tables, and provides a comprehensive analysis of thePOC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.......
  • Drugs of Abuse Diagnostics Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 318-page report from VPGMarketResearch.com contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment ......
  • France Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualon......
  • Germany Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 262-page report from VPGMarketResearch.com provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualo......
  • Italy Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualo......
  • Japan Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqual......
  • Spain Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualo......
  • UK Drugs of Abuse Diagnostics Market 2021: Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, O......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs